Articles with public access mandates - Ralph ButtyanLearn more
Not available anywhere: 3
Gli activation by the estrogen receptor in breast cancer cells: Regulation of cancer cell growth by Gli3
S Massah, J Foo, N Li, S Truong, M Nouri, L Xie, GS Prins, R Buttyan
Molecular and cellular endocrinology 522, 111136, 2021
Mandates: Canadian Institutes of Health Research
Inhibition of GLI2 with antisense‐oligonucleotides: A potential therapy for the treatment of bladder cancer
PA Raven, S Lysakowski, Z Tan, NM D'Costa, I Moskalev, S Frees, ...
Journal of Cellular Physiology 234 (11), 20634-20647, 2019
Mandates: Canadian Institutes of Health Research
ANDROGEN REGULATES THE EXPRESSION OF CRITICAL HEDGEHOG SIGNALING COMPONENTS IN PROSTATE CANCER CELLS
M Chen, M Tanner, AC Levine, E Levina, R Buttyan
The Journal of Urology 181 (4S), 96-96, 2009
Mandates: US National Institutes of Health
Available somewhere: 27
Class III β-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy
G Ploussard, S Terry, P Maillé, Y Allory, N Sirab, L Kheuang, P Soyeux, ...
Cancer research 70 (22), 9253-9264, 2010
Mandates: National Institute of Health and Medical Research, France
FOXC1 activates smoothened-independent hedgehog signaling in basal-like breast cancer
B Han, Y Qu, Y Jin, Y Yu, N Deng, K Wawrowsky, X Zhang, N Li, S Bose, ...
Cell reports 13 (5), 1046-1058, 2015
Mandates: US National Institutes of Health
Increased expression of class III β-tubulin in castration-resistant human prostate cancer
S Terry, G Ploussard, Y Allory, N Nicolaiew, F Boissiere-Michot, P Maille, ...
British journal of cancer 101 (6), 951-956, 2009
Mandates: National Institute of Health and Medical Research, France
Not all NOTCH is created equal: the oncogenic role of NOTCH2 in bladder cancer and its implications for targeted therapy
T Hayashi, KM Gust, AW Wyatt, A Goriki, W Jäger, S Awrey, N Li, HZ Oo, ...
Clinical Cancer Research 22 (12), 2981-2992, 2016
Mandates: Canadian Cancer Society
Expression and function of the progesterone receptor in human prostate stroma provide novel insights to cell proliferation control
Y Yu, L Liu, N Xie, H Xue, L Fazli, R Buttyan, Y Wang, M Gleave, X Dong
The Journal of Clinical Endocrinology & Metabolism 98 (7), 2887-2896, 2013
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome
N Stylianou, ML Lehman, C Wang, AT Fard, A Rockstroh, L Fazli, ...
Oncogene 38 (7), 913-934, 2019
Mandates: National Health and Medical Research Council, Australia
The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management
VR Ramnarine, M Kobelev, EA Gibb, M Nouri, D Lin, Y Wang, R Buttyan, ...
European urology 76 (5), 546-559, 2019
Mandates: Prostate Cancer Canada
Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ2 renders tumor cells dependent on its paralogous gene COPZ1
M Shtutman, M Baig, E Levina, G Hurteau, C Lim, E Broude, M Nikiforov, ...
Proceedings of the National Academy of Sciences 108 (30), 12449-12454, 2011
Mandates: US National Institutes of Health
Androgenic regulation of hedgehog signaling pathway components in prostate cancer cells
M Chen, M Tanner, AC Levine, E Levina, PY Ohouo, R Buttyan
Cell cycle 8 (1), 149-157, 2009
Mandates: US National Institutes of Health
Therapy-induced developmental reprogramming of prostate cancer cells and acquired therapy resistance
M Nouri, J Caradec, AA Lubik, N Li, BG Hollier, M Takhar, ...
Oncotarget 8 (12), 18949, 2017
Mandates: Canadian Institutes of Health Research, Prostate Cancer Canada
Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
M Chen, MA Feuerstein, E Levina, PS Baghel, RD Carkner, MJ Tanner, ...
Molecular cancer 9, 1-12, 2010
Mandates: US National Institutes of Health
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer
N Singh, VR Ramnarine, JH Song, R Pandey, SKR Padi, M Nouri, V Olive, ...
Nature communications 12 (1), 7349, 2021
Mandates: US Department of Defense, US National Institutes of Health, Canadian …
The hedgehog/Gli signaling paradigm in prostate cancer
M Chen, R Carkner, R Buttyan
Expert review of endocrinology & metabolism 6 (3), 453-467, 2011
Mandates: US National Institutes of Health
FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype
DJ DeGraff, MM Grabowska, TC Case, X Yu, MK Herrick, WJ Hayward, ...
Laboratory investigation 94 (7), 726-739, 2014
Mandates: US National Institutes of Health
Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cells
KJ Tam, DHF Hui, WW Lee, M Dong, T Tombe, IZF Jiao, S Khosravi, ...
Scientific reports 7 (1), 11501, 2017
Mandates: US National Institutes of Health, Canadian Cancer Society, Natural Sciences …
The stress response mediator ATF3 represses androgen signaling by binding the androgen receptor
H Wang, M Jiang, H Cui, M Chen, R Buttyan, SW Hayward, T Hai, Z Wang, ...
Molecular and cellular biology, 2012
Mandates: US National Institutes of Health
Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3
N Li, S Truong, M Nouri, J Moore, N Al Nakouzi, AA Lubik, R Buttyan
Oncogene 37 (17), 2313-2325, 2018
Mandates: US Department of Defense, Canadian Institutes of Health Research, Prostate …
Publication and funding information is determined automatically by a computer program